Cardiol Therapeutics Stock
Cardiol Therapeutics Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- David G. Elsley
- Employees
- 18
- Market cap
- $191 M
- IPO
- 20/12/2018
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III…
Cardiol Therapeutics stock: price history
1D
-1.3%
1W
-11.2%
1M
-39.7%
6M
-23.3%
YTD
+20.6%
1Y
+8.2%
2Y
-39.7%
5Y
-67.4%
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~7% stronger price swings than usual
Ask the agents about Cardiol Therapeutics
Analyst assessment of Cardiol Therapeutics
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 23/09/2026
Cardiol Therapeutics stock metrics
P/E
-4.59
P/B
7.56
EV/EBITDA
-4.63
RETURN ON EQUITY
-25.3%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
76.2%
FLOAT SHARES
91,975,657
AVG. DAILY VOLUME (30D)
280,263
Comparable stocks
Frequently asked questions about Cardiol Therapeutics stock
What does Cardiol Therapeutics do?
Cardiol Therapeutics Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is David G. Elsley, the company employs around 18 people.
The IPO was on 20/12/2018; the stock trades on TSX under the ticker CRDL.TO.
What do analysts say about Cardiol Therapeutics stock?
3 analysts rate the stock, the consensus is Buy (as of 23/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Cardiol Therapeutics report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 7% stronger than usual.
Does Cardiol Therapeutics pay a dividend?
No, Cardiol Therapeutics currently does not pay a dividend.
Which stocks are comparable to Cardiol Therapeutics?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Cardiol Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cardiol Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.